The University of Queensland (UQ) has strengthened its engagement with the University of Alberta (UoA) to address shared global challenges including energy transition, health, and Indigenous futures, while strengthening collaboration across emerging and enabling technologies.
Queensland will be a major international hub for vaccine discovery and development with a $32 million partnership secured between The University of Queensland and US-based Emory University, with support from the Queensland Government, to establish the Queensland Emory Vaccine Centre (QEVC) at UQ.
The University of Queensland’s small molecule drug discovery facility will open its doors to researchers from across Australia for the first time thanks to a National Collaborative Research Infrastructure Strategy (NCRIS) funding injection.
A unique partnership between The University of Queensland (UQ) and Ochsner Health (Ochsner) has been extended until at least 2030 and will continue to grow the world’s physician pipeline through a transnational Doctor of Medicine (MD) program.
Queensland will become a major international hub for vaccine discovery and development with a global partnership formed in the United States today to help address the world’s critical health challenges.
Funded by the Queensland Government, Vaxxas has opened a facility in Brisbane, Australia to support the production of its high-density microarray patches.
Following a competitive selection process, 5 outstanding initiatives have received funding totalling $47,000 in the latest UQ Global Strategy and Partnership Seed Funding Scheme.
UQ, Oxford and Princeton researchers have developed a "test" to measure if businesses are on track to meet Paris Agreement climate action goals, and so far the results are not promising.
